NYSE Composite opens in less than two hours and Novartis AG’s pre-market value is already 3.66% down.
The last session, NYSE Composite ended with Novartis AG jumping 1.62% to $98.47. NYSE Composite fell 0.11% to $14,935.29, after three consecutive sessions in a row of losses, on what was a somewhat negative trend exchanging session.
Novartis AG’s last close was $96.90, 1.39% below its 52-week high of $99.84.
Novartis AG’s Sales
Novartis AG’s sales growth is 3.7% for the current quarter and 6.8% for the next. The company’s growth estimates for the current quarter and the next is 3% and 1.3%, respectively.
Novartis AG’s Revenue
Year-on-year quarterly revenue growth grew by 0.4%, now sitting on 49.58B for the twelve trailing months.
Novartis AG’s Stock Yearly Top and Bottom Value
Novartis AG’s stock is valued at $98.47 at 07:52 EST, below its 52-week high of $99.84 and way above its 52-week low of $69.18.
Novartis AG’s Moving Average
Novartis AG’s value is above its 50-day moving average of $92.78 and way higher than its 200-day moving average of $87.78.
Novartis AG’s last day, last week, and last month’s average volatility was 0.02%, 0.48%, and 0.44%, respectively.
Novartis AG’s last day, last week, and last month’s high and low average amplitude percentage was 1.00%, 0.88%, and 1.02%, respectively.